Skip to content

My Best Medicine

mybestmedicine.com

  • Health News
  • Medications
  • Fitness
  • Family Health
  • Beauty & Balance

Home » Medications

Second Interim Analysis of Clinical Trial Data Showed a 91.4% Efficacy for the Sputnik V Vaccine on Day 28 After the First Dose; Vaccine Efficacy is Over 95% 42 days After the First Dose

25/11/2020 Medications

The efficacy of the Sputnik V vaccine is 91.4%, based

Read more

Pfizer Update On Our U.S. COVID-19 Vaccine Candidate Distribution Preparedness

19/11/2020 Medications

NEW YORK, 16 November 2020 — Pfizer (NYSE: PFE) today announced the U.S. COVID-19

Read more

Bristol Myers Squibb Announces Deucravacitinib (BMS-986165) Demonstrated Superiority to Placebo and Otezla® (apremilast) in Pivotal Phase 3 Psoriasis Study

13/11/2020 Medications

PRINCETON, N.J.–(BUSINESS WIRE) November 3, 2020 — Bristol Myers Squibb

Read more

NIH Begins Large Clinical Trial to Test Immune Modulators for Treatment of COVID-19

19/10/2020 Medications

October 16, 2020 — The National Institutes of Health has

Read more

Merck Presents Three-Year Survival Data for Keytruda (pembrolizumab) in Combination With Chemotherapy and Updated Phase 1/2 Data for Investigational Quavonlimab (MK-1308) in Combination With Keytruda in Advanced Non‑Small Cell Lung Cancer

19/10/2020 Medications

KENILWORTH, N.J.–(BUSINESS WIRE) October 16, 2020 — Merck (NYSE: MRK),

Read more

Vaxart Announces Dosing First Subject in Phase 1 Clinical Trial of Its Oral Tablet COVID-19 Vaccine

14/10/2020 Medications

SOUTH SAN FRANCISCO, Calif., Oct. 13, 2020 (GLOBE NEWSWIRE) — Vaxart, Inc., (NASDAQ:

Read more

Pfizer and Sangamo Dose First Participant in Phase 3 Study Evaluating Hemophilia A Gene Therapy Treatment SB-525

08/10/2020 Medications

NEW YORK & BRISBANE, Calif.–(BUSINESS WIRE) October 07, 2020 —

Read more

Horizon Therapeutics plc Announces U.S. FDA Approval of New Dosage Form for Procysbi (Cysteamine Bitartrate) Delayed-Release Oral Granules

22/02/2020 Medications

DUBLIN–(BUSINESS WIRE)–February 18, 2020 — Horizon Therapeutics plc (Nasdaq: HZNP)

Read more

U.S. FDA Grants Priority Review for Kite’s KTE-X19 Biologics License Application (BLA) in Relapsed or Refractory Mantle Cell Lymphoma

14/02/2020 Medications

SANTA MONICA, Calif.–(BUSINESS WIRE)–Feb. 10, 2020– Kite, a Gilead Company (Nasdaq: GILD),

Read more

Genentech’s Risdiplam Meets Primary Endpoint in Pivotal FIREFISH Trial in Infants With Type 1 Spinal Muscular Atrophy

09/02/2020 Medications

South San Francisco, CA — January 22, 2020 — Genentech,

Read more

Posts navigation

1 2 3 … 17 Next Posts»
Latest Posts
New gene therapy developed for treating eye disease that leads to a progressive loss of vision
Nurse Practitioners Key to Opioid Treatment in Rural U.S.: Study
Why gratitude matters—even during a pandemic
BEAUTY
Unilever to Acquire SmartyPants Vitamins
How Beauty’s Biggest Bankers Celebrate Deals
Recent Posts
  • New gene therapy developed for treating eye disease that leads to a progressive loss of vision
  • Nurse Practitioners Key to Opioid Treatment in Rural U.S.: Study
  • Why gratitude matters—even during a pandemic
  • EU fines Teva over delaying cheap sleep disorder drug
  • Lithuania finds coronavirus in minks at one farm
Copyright © 2020
We and our partners use cookies on this site to improve our service, perform analytics, personalize advertising, measure advertising performance, and remember website preferences.Ok